Article History
Received: 16 January 2023
Revised: 16 February 2023
Accepted: 21 February 2023
First Online: 1 March 2023
Competing interests
: Dr. Mehmet Akce has received research support from Tesaro, RedHill Biopharma, Polaris, Bristol-Myers-Squibb-Ono Pharmaceutical, Xencor, Merck Sharp& Dohme, Eisai, GSK, and AstraZeneca. Dr. Mehmet Akce has also served as a consultant for Eisai, Ipsen, Exelixis, GSK, QED, Isofol, Curio Science, AstraZeneca, Genentech. Dr. Bassel El-Rayes has received research support from EUSA, Novartis, BMS, Exelixis, Xencor, Merck, Adaptimmune. Dr. Bassel El-Rayes has also served as a consultant for IPSEN, BMS, AstraZeneca, deciphera, neogenomics, DSMB, Exelixis, and Erytech. Dr. Narendra Wajapeyee has no conflict of interest to declare.